Loss-of-Function Mutations

A loss-of-function mutation reduces or abolishes the activity of a gene product. It is the most common mechanism of monogenic disease and usually acts recessively, because one normal allele is often enough to maintain function, but it can act dominantly when half the normal dose is itself insufficient.

Definition

A loss-of-function mutation is a variant that decreases or eliminates the normal activity of a gene product, ranging from a partial reduction (hypomorph) to a complete null (amorph), and most often produces disease when both alleles are affected.

Scope

The entry covers what loss of function means at the molecular level, the spectrum from partial (hypomorphic) to complete (amorphic/null) loss, why such variants are typically recessive, and the special case of haploinsufficiency that makes some of them dominant. It is a conceptual topic within single-gene disorders and is not clinical guidance.

Core questions

• What does it mean for a mutation to cause loss of function?
• Why are most loss-of-function mutations recessive?
• When does losing one allele cause disease (haploinsufficiency)?
• How does a partial loss (hypomorph) differ from a complete null?

Key concepts

• Amorph (null allele) versus hypomorph (partial loss)
• Recessive inheritance and one sufficient allele
• Haploinsufficiency
• Nonsense-mediated decay of truncating variants
• Compound heterozygosity

Key theories

Recessivity of loss-of-function alleles and haploinsufficiency

Wilkie's account of dominance explains that loss-of-function alleles are usually recessive because one functional allele suffices, but become dominant through haploinsufficiency when the reduced gene dosage from a single working allele cannot meet functional demand.

Mechanisms

Loss of function can arise from variants that truncate the protein, disrupt splicing, abolish expression, or impair folding or catalysis. In Muller's terms a complete null is an amorph and a partial reduction is a hypomorph. Such alleles are typically recessive because a single functional allele can supply enough product; disease then requires both alleles to be affected, either homozygous for one variant or compound heterozygous for two. When the amount made by one functional allele is not enough, the gene is haploinsufficient and a single loss-of-function allele causes a dominant phenotype, as Wilkie discusses among the bases of dominance. Cystic fibrosis illustrates a recessive loss-of-function disorder, with the CFTR gene identified by Riordan and colleagues.

Clinical relevance

Classifying a variant as loss of function is central to interpreting its likely consequence and inheritance pattern in genetic curation and research. The concept explains why two carriers can have an affected child and why some genes cause disease with a single damaged allele. This is descriptive background and not a basis for individual diagnosis or treatment.

History

Hermann Muller's 1932 mutation classes named the amorph (complete loss) and hypomorph (partial loss), giving loss of function its classical vocabulary. The molecular cloning era confirmed loss-of-function mechanisms in named disorders such as cystic fibrosis in 1989, and Wilkie's 1994 synthesis clarified when loss of function is recessive and when haploinsufficiency makes it dominant.

Key figures

• Andrew Wilkie
• Hermann J. Muller
• Lap-Chee Tsui
• John Riordan

Seminal works

• wilkie-1994
• riordan-1989

Frequently asked questions

Why are loss-of-function mutations usually recessive?

For many genes a single working allele makes enough product to keep the cell functioning, so disease appears only when both alleles are damaged.

What is haploinsufficiency?

It is the situation where one working allele does not make enough product, so losing the other allele's function is enough to cause a dominant phenotype.